Literature DB >> 29356609

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Megan A Clarke1, Barbara Fetterman1, Li C Cheung1, Nicolas Wentzensen1, Julia C Gage1, Hormuzd A Katki1, Brian Befano1, Maria Demarco1, John Schussler1, Walter K Kinney1, Tina R Raine-Bennett1, Thomas S Lorey1, Nancy E Poitras1, Philip E Castle1, Mark Schiffman1.   

Abstract

Purpose Obesity has been inconsistently linked to increased cervical cancer incidence and mortality; however, the effect of obesity on cervical screening has not been explored. We investigated the hypothesis that increased body mass might decrease detection of cervical precancer and increase risk of cervical cancer even in women undergoing state-of-the-art screening. Methods We conducted a retrospective cohort study of 944,227 women age 30 to 64 years who underwent cytology and human papillomavirus DNA testing (ie, cotesting) at Kaiser Permanente Northern California (January 2003 to December 2015). Body mass index was categorized as normal/underweight (< 25 kg/m2), overweight (25 to < 30 kg/m2), or obese (≥ 30 kg/m2). We estimated 5-year cumulative risks of cervical precancer and cancer by category of body mass index using logistic Weibull survival models. Results We observed lower risk of cervical precancer (n = 4,489) and higher risk of cervical cancer (n = 490) with increasing body mass index. Specifically, obese women had the lowest 5-year risk of precancer (0.51%; 95% CI, 0.48% to 0.54% v 0.73%; 95% CI, 0.70% to 0.76% in normal/underweight women; P trend < .001). In contrast, obese women had the highest 5-year risk of cancer (0.083%; 95% CI, 0.072% to 0.096% v 0.056%; 95% CI, 0.048% to 0.066% in normal/underweight women; P trend < .001). Results were consistent in subgroups defined by age (30 to 49 v 50 to 64 years), human papillomavirus status (positive v negative), and histologic subtype (glandular v squamous). Approximately 20% of cervical cancers could be attributed to overweight or obesity in the women in our study who underwent routine cervical screening. Conclusion In this large, screened population, overweight and obese women had an increased risk of cervical cancer, likely because of underdiagnosis of cervical precancer. Improvements in equipment and/or technique to assure adequate sampling and visualization of women with elevated body mass might reduce cervical cancer incidence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29356609      PMCID: PMC5908221          DOI: 10.1200/JCO.2017.75.3442

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  35 in total

1.  Prevalence of Obesity Among Adults and Youth: United States, 2011-2014.

Authors:  Cynthia L Ogden; Margaret D Carroll; Cheryl D Fryar; Katherine M Flegal
Journal:  NCHS Data Brief       Date:  2015-11

2.  Physical activity and weight gain prevention.

Authors:  I-Min Lee; Luc Djoussé; Howard D Sesso; Lu Wang; Julie E Buring
Journal:  JAMA       Date:  2010-03-24       Impact factor: 56.272

3.  Change in height, weight and body mass index: Longitudinal data from the HUNT Study in Norway.

Authors:  W B Drøyvold; T I L Nilsen; O Krüger; T L Holmen; S Krokstad; K Midthjell; J Holmen
Journal:  Int J Obes (Lond)       Date:  2006-06       Impact factor: 5.095

4.  Re: The Impact of Obesity on the Predictive Accuracy of PSA in Men Undergoing Prostate Biopsy.

Authors:  Steven A Kaplan
Journal:  J Urol       Date:  2015-05-15       Impact factor: 7.450

5.  Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports.

Authors:  Raul N Uppot; Dushyant V Sahani; Peter F Hahn; Mannudeep K Kalra; Sanjay S Saini; Peter R Mueller
Journal:  Radiology       Date:  2006-06-26       Impact factor: 11.105

6.  2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia.

Authors:  Thomas C Wright; J Thomas Cox; L Stewart Massad; Jay Carlson; Leo B Twiggs; Edward J Wilkinson
Journal:  J Low Genit Tract Dis       Date:  2003-07       Impact factor: 1.925

7.  Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation.

Authors:  Barbara Sternfeld; Hua Wang; Charles P Quesenberry; Barbara Abrams; Susan A Everson-Rose; Gail A Greendale; Karen A Matthews; Javier I Torrens; MaryFran Sowers
Journal:  Am J Epidemiol       Date:  2004-11-01       Impact factor: 4.897

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.

Authors:  Nora T Kizer; Premal H Thaker; Feng Gao; Israel Zighelboim; Matthew A Powell; Janet S Rader; David G Mutch; Perry W Grigsby
Journal:  Cancer       Date:  2010-10-13       Impact factor: 6.860

10.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

View more
  17 in total

1.  Trends and predictors of hysterectomy prevalence among women in the United States.

Authors:  Summer V Harvey; Ruth M Pfeiffer; Rebecca Landy; Nicolas Wentzensen; Megan A Clarke
Journal:  Am J Obstet Gynecol       Date:  2022-06-25       Impact factor: 10.693

2.  The prognostic value of chemotherapy or/and radiotherapy in adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix.

Authors:  Kun Liu; Yong Shi; Lili Qiao; Guodong Deng; Ning Liang; Jian Xie
Journal:  Ann Transl Med       Date:  2022-05

3.  Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results.

Authors:  Maria Demarco; Didem Egemen; Noorie Hyun; Xiaojian Chen; Anna-Barbara Moscicki; Li Cheung; Olivia Carter-Pokras; Anne Hammer; Julia C Gage; Megan A Clarke; Philip E Castle; Brian Befano; Jie Chen; Cher Dallal; Xin He; Kanan Desai; Thomas Lorey; Nancy Poitras; Tina R Raine-Bennett; Rebecca B Perkins; Nicolas Wentzensen; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2022-04-01       Impact factor: 3.842

4.  The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.

Authors:  Julia C Gage; Tina Raine-Bennett; Mark Schiffman; Megan A Clarke; Li C Cheung; Nancy E Poitras; Nicole E Varnado; Hormuzd A Katki; Philip E Castle; Brian Befano; Malini Chandra; Greg Rydzak; Thomas Lorey; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-17       Impact factor: 4.090

5.  Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020.

Authors:  Rebecca B Perkins; Richard L Guido; Mona Saraiya; George F Sawaya; Nicolas Wentzensen; Mark Schiffman; Sarah Feldman
Journal:  J Womens Health (Larchmt)       Date:  2021-01       Impact factor: 2.681

Review 6.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 7.  Reprogramming of Fatty Acid Metabolism in Gynaecological Cancers: Is There a Role for Oestradiol?

Authors:  Azilleo Kristo Mozihim; Ivy Chung; Nur Akmarina B M Said; Amira Hajirah Abd Jamil
Journal:  Metabolites       Date:  2022-04-14

Review 8.  Hidden analyses: a review of reporting practice and recommendations for more transparent reporting of initial data analyses.

Authors:  Marianne Huebner; Werner Vach; Saskia le Cessie; Carsten Oliver Schmidt; Lara Lusa
Journal:  BMC Med Res Methodol       Date:  2020-03-13       Impact factor: 4.615

Review 9.  The Crosstalk Between Adipose-Derived Stem or Stromal Cells (ASC) and Cancer Cells and ASC-Mediated Effects on Cancer Formation and Progression-ASCs: Safety Hazard or Harmless Source of Tropism?

Authors:  Vincent G J Guillaume; Tim Ruhl; Anja M Boos; Justus P Beier
Journal:  Stem Cells Transl Med       Date:  2022-04-29       Impact factor: 7.655

10.  Adipose-derived mesenchymal stem cells promote the malignant phenotype of cervical cancer.

Authors:  Rosario Castro-Oropeza; Karla Vazquez-Santillan; Claudia Díaz-Gastelum; Jorge Melendez-Zajgla; Cecilia Zampedri; Eduardo Ferat-Osorio; Arturo Rodríguez-González; Lourdes Arriaga-Pizano; Vilma Maldonado
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.